8-K filing — SRX Global Inc. (SRXH)
Filed: 2026-09-02 AccNo: 0001493152-26-041250 Size: 706 KB Item 1.01: Entry into a Material Definitive Agreement Item 9.01: Financial Statements and Exhibits
Stocks · News reference
SRX HealthSolutions Q3 2026 Earnings Call: Complete Transcript
On Thursday, SRX HealthSolutions (AMEX:SRXH) discussed third-quarter financial results during its earnings call. The full transcript is provided below. This content is powered by Benzinga APIs. For comprehensive
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
SRX Global Announces Purchase Of Senior Secured Debt In CERo Therapeutics Holdings; Terms Not Disclosed
SRX HealthSolutions Q3 EPS $(0.36) Up From $(44.51) YoY, Sales $3.392M Up From $2.673M YoY
SRX HealthSolutions (AMEX:SRXH) reported quarterly losses of $(0.36) per share. This is a 99.19 percent increase over losses of $(44.51) per share from the same period last year. The company reported $3.392 million in